RAPIDe-3 In partnership with about 75 other institutions across the globe, the practice of Dr. Raffi Tachdjian is currently participating in the RAPIDe-3 study on hereditary angioedema (HAE) type 1 and type 2. The purpose of this study is to evaluate the efficacy and safety of an oral investigational drug,…
Sponsored Content
Recent Posts
- A lived example helped me better understand my daughter with HAE
- Ekterly pill may change how families treat HAE attacks in young children
- HAE attacks make travel more burdensome due to triggers
- Takhzyro safely prevents HAE attacks in real world in patients in Puerto Rico
- Blood pressure medication causes rare life-threatening reaction after 11 years